KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Hematology / 2011 / Cilt: 28 - Sayı: 3

Arnavut popülasyonunda FV G1691A ve PT G20210A mutasyonu sıklığı

The frequency of FV G1691A and PT G20210A mutations in an Albanian population

Mustafa TEKİN
A. Avni ATAY
Klodian ALLAJALEBEU
Nejat AKAR
Yonca EĞİN
Sayfa
241–242
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

TEKİN, M., ATAY, A. A., ALLAJALEBEU, K., AKAR, N., EĞİN, Y. (2022). Arnavut popülasyonunda FV G1691A ve PT G20210A mutasyonu sıklığı. Turkish Journal of Hematology, Cilt: 28 - Sayı: 3, 241–242. https://ajindex.com/articles/606980

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (8)

  1. Lane DA, Grant GJ. Role of hemostatic gene polymor- phisms in venous and arterial thrombotic disease, Blood 2000;95:1517-32.
  2. Heijboer H, Brandjes DP Buller HR, Sturk A, Ten Cate JW. Deficiencies of coagulation-inhibiting and fibrino- lytic proteins in outpatients with deep-vein thrombosis. N Engl Med 1990;323:1512-6.
  3. Dahlback B, Carlsson M, Svensson PJ. Familial throm- bophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to acti- vated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004-8.
  4. Poort SR, Rosendall FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
  5. Rees DC, Cox M, Clegg JB. World Distrubition of factor V Leiden. Lancet 1995;346:1133-4. Rosendall FR. Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706-8.
  6. Akar N, Dalgın G, Sözüöz A, Ömürlü K, Cin Ş. Frequency of factor V (1691 G-A) mutation in Turkish population. Thromb Haemost 1997;78:1527-8. Akar N. Factor V 1691 G-A mutation distribution in a healthy Turkish population. Turk J Hematol 2009;26:9-11.
  7. Akar N, Mısırlıoğlu M, Akar E, Avcu F, Yalçın A, Sözüöz A. Prothrombin gene 20210 G-A mutation in the Turkish population. Am J Hematol 1998;58:249. Bauduer F, Lacombe D. Factor V Leiden, prothrombin 20210A, methylenetetrahydrofolate reductase 677T, and population genetics. Mol Genet Metab. 2005;86:91-9. Akar N. Molecular biology for clinicians: Site specific mutagenesis: Usage for the mutation detection in thrombosis. Turk J Hematol 1998;15:123-4. García-Gala JM, Alvarez V, Pinto CR, Soto I, Urgellés MF, Menéndez MJ, Carracedo C, López-Larrea C, Coto E. Factor V Leiden (R506Q) and risk of venous thrombo- embolism: a case-control study based on the Spanish population. Clin Genet 1997;52:206-10.
  8. Mannucci PM, Duca F, Peyvandi F, et al. Frequency of factor V Arg506 Gln in Italians. Tromb Haemost 1996;75:694. Antoniadi T, Hatzis T, Kroupis C, et al. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in a Greek population of blood donors. Am J Hematol 1999;61:265-7.